	US 12,029,806 B2
	Topical composition for treating bad body odors, in particular halitosis
Léon Mentink, Lille (FR); Daniel Wils, Morbecque (FR); Géraldine Louvet-Pommier, Lachelle (FR); and Sophie Piot, Paris (FR)
Assigned to Roquette Freres, Lestrem (FR)
Appl. No. 17/593,730
Filed by ROQUETTE FRERES, Lestrem (FR)
PCT Filed Mar. 27, 2020, PCT No. PCT/EP2020/058679 § 371(c)(1), (2) Date Sep. 23, 2021, PCT Pub. No. WO2020/193743, PCT Pub. Date Oct. 1, 2020.
Claims priority of application No. 1903283 (FR), filed on Mar. 28, 2019.
Prior Publication US 2022/0192962 A1, Jun. 23, 2022
Int. Cl. A61K 8/73 (2006.01); A61K 8/49 (2006.01); A61Q 11/00 (2006.01); A61Q 15/00 (2006.01)

CPC A61K 8/738 (2013.01) [A61K 8/4973 (2013.01); A61Q 11/00 (2013.01); A61Q 15/00 (2013.01)]

14 Claims

1. A method for treating, preventing, reducing or eliminating bad body odors to a subject in need thereof, comprising the step of administering a composition comprising an anti-odor agent to said subject and thereby treating, preventing or eliminating bad body odors, and wherein the anti-odor agent comprises:

at least one modified cyclodextrin selected from hydroxypropylated alpha-cyclodextrins, hydroxypropylated beta-cyclodextrins, hydroxypropylated gamma-cyclodextrins, and

isosorbide.